Therapeutic Advances in Endocrinology and Metabolism (Jan 2019)

Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET

  • Ruo-Qiang Wang,
  • Yu-Long Lan,
  • Jia-Cheng Lou,
  • Yi-Zhu Lyu,
  • Yu-Chao Hao,
  • Qian-Fei Su,
  • Bin-Bin Ma,
  • Zhong-Bo Yuan,
  • Zhi-Kuan Yu,
  • Hong-Qiang Zhang,
  • Dong-Sheng Wang,
  • Ting-Zhun Zhu,
  • Yan Ding,
  • Ning Zhang,
  • Bo Zhang

DOI
https://doi.org/10.1177/2042018818821296
Journal volume & issue
Vol. 10

Abstract

Read online

The laminin subunit alpha 2 (LAMA2) gene encodes an alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). In the current study, we investigated the relationship between LAMA2 promoter methylation status and the invasiveness of clinically nonfunctioning pituitary adenomas (PitNETs). Specimens from patients with nonfunctioning PitNET were classified into three groups according to preoperative computed tomography (CT)/magnetic resonance imaging findings: a normal group ( n = 6), non-invasive group ( n = 11) and invasive group ( n = 6). LAMA2 expression was assessed using quantitative real-time polymerase chain reaction (RT-qPCR) and western blotting, and the methylation status of the LAMA2 promoter region was observed using sodium bisulfite sequencing. Furthermore, 5-aza-2-deoxycytidine was used to explore the relationship between decreased LAMA expression and methylation in PitNET cells. According to the RT-qPCR and western blotting results, LAMA2 expression was downregulated in invasive PitNET, while the methylation of the LAMA2 promoter was increased. Methylation of the LAMA2 promoter decreased the expression of LAMA2. Thus, changes in LAMA2 expression due to promoter methylation were inversely correlated with the invasiveness of PitNET and the protein functions as a tumor suppressor. In addition, overexpression and demethylation of LAMA2 suppressed the invasion of PitNET cells, partially by exerting effects on the PTEN-PI3K/AKT signaling pathway and matrix metalloproteinase-9 (MMP-9). Furthermore, a xenograft model was also generated, and LAMA2 overexpression significantly suppressed tumor growth in vivo . Thus, LAMA2 expression and methylation patterns might be used as biomarkers to predict the prognosis of patients with PitNET.